Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/11/24 15:27 | 3/11/24 | HARP | Health | Drug | Pharmaceutical Preparations | Merck & Co., Inc. | NJ | T | P | 492,136 | 23.00 | 0 | 21,397 | 1 | I | ||||||||||||||||
10/27/23 16:41 | 10/25/23 | HARP | Health | BioPrd | Biological Products, (No Diag | New Leaf Biopharma Opportunities Ii, L.P. | NY | T | P.d | 0 | 0.00 | 0 | 1,544 | 474 | 1,869 | M | |||||||||||||||
10/27/23 16:03 | 10/25/23 | HARP | Health | BioPrd | Biological Products, (No Diag | Hunt Ronald | NY | DT | P.d | 0 | 0.00 | 0 | 1,544 | 413 | I | ||||||||||||||||
3/27/23 17:37 | 3/23/23 | HARP | Health | BioPrd | Biological Products, (No Diag | Hunt Ronald | NY | DT | P.d | 10,000 | 1,000.0 | 0 | 10 | 0 | 3,167 | I | |||||||||||||||
9/22/21 21:30 | 9/22/21 | HARP | Health | BioPrd | Biological Products, (No Diag | Erbez Georgia | CA | O | CFO | P | 83 | 8.10 | 0 | 10 | 12 | 98 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |